The analysis, which considers different scenarios of how the pandemic will play out, projects costs in the national commercial market to range from $34 billion to $251 billion. Cost includes testing, treatment and COVID-19 care.
When compared to premium, the analysis predicts COVID-19 costs could range from about 2 percent of premium to more than 21 percent of premium.
Health insurers are in the process of setting their rates for 2021. With these costs in mind, health insurers may raise their premiums between 4 percent and more than 40 percent to recoup 2020 losses, according to the analysis.
More articles on payers:
16 insurers waiving costs for COVID-19 treatment
Trump administration to use hospital stimulus funds to pay for uninsured COVID-19 treatment
Humana to expedite claim processing, suspend more prior authorization rules
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.